Skip to main content
SpringerLink
Log in

Raynaud’s Phenomenon

  • Chapter
Vascular Surgery

  • 1066 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. LeRoy EC, Medsger TA. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485–8.

    PubMed  CAS  Google Scholar 

  2. Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology (in press).

    Google Scholar 

  3. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4:351–68.

    Article  PubMed  CAS  Google Scholar 

  4. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 1973:16:619–28.

    PubMed  CAS  Google Scholar 

  5. Harvey GR, McHugh NJ. Serologic abnormalities in systemic sclerosis. Curr Op Rheumatol 1999;11:495–502.

    Article  CAS  Google Scholar 

  6. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.

    PubMed  CAS  Google Scholar 

  7. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 1992;35:688–93.

    PubMed  CAS  Google Scholar 

  8. Harrison BJ, Silman AJ, Hider SL, Herrick AL. Cigarette smoking: a significant risk factor for digital vascular diseases in patients with systemic sclerosis. Arthritis Rheum 2002:46:3312–16.

    Article  PubMed  Google Scholar 

  9. Thompson AE, Shea B, Welch V, Fenlon D, Pope JE. Calcium-channel blockers for Raynaud’s phenomenon in systemic sclerosis. Arthritis Rheum 2001;44:1841–7.

    Article  PubMed  CAS  Google Scholar 

  10. Herrick AL. Treatment of Raynaud’s phenomenon — update, new insights and developments. Curr Rheumatol Rep 2003:5:168–74.

    PubMed  Google Scholar 

  11. Raynaud’s Treatment Study Investigators: Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up. Arch Intern Med 2000;160:1101–8.

    Google Scholar 

  12. Wigley FM, Wise RA, Seibold JR, et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994;120:199–206.

    PubMed  CAS  Google Scholar 

  13. Tomaino MM, Goitz RJ, Medsger TA. Surgery for ischemic pain and Raynaud’s phenomenon in scleroderma: a description of treatment protocol and evaluation of results. Microsurgery 2001;21:75–9.

    Article  PubMed  CAS  Google Scholar 

  14. Ho M, Veale D, Eastmond C, Nuki G, Belch J. Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000;59:39–43.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatic Diseases Centre, University of Manchester, Hope Hospital, Salford, UK

    Ariane L. Herrick MD, FRCP

Authors
  1. Ariane L. Herrick MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Vascular Medicine, Royal Society of Medicine, London, UK

    George Geroulakos MD, FRCS, DIC, PhD (President and Consultant Vascular Surgeon and Senior Lecturer) (President and Consultant Vascular Surgeon and Senior Lecturer)

  2. Department of Surgery, Charing Cross Hospital, London, UK

    George Geroulakos MD, FRCS, DIC, PhD (President and Consultant Vascular Surgeon and Senior Lecturer) (President and Consultant Vascular Surgeon and Senior Lecturer)

  3. Erasmus University Medical Center, Rotterdam, The Netherlands

    Hero van Urk MD, PhD, FRCS (Professor of Vascular Surgery) (Professor of Vascular Surgery)

  4. Division of Vascular Surgery, UMDNJ-NJMS (University of Medicine and Dentistry of New Jersey — New Jersey Medical School), Newark, New Jersey, USA

    Robert W. Hobson II MD (Professor of Surgery and Physiology, Director) (Professor of Surgery and Physiology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Herrick, A.L. (2006). Raynaud’s Phenomenon. In: Geroulakos, G., van Urk, H., Hobson, R.W. (eds) Vascular Surgery. Springer, London . https://doi.org/10.1007/1-84628-211-X_36

Download citation

  • DOI: https://doi.org/10.1007/1-84628-211-X_36

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-963-0

  • Online ISBN: 978-1-84628-211-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation